Recce Pharmaceuticals Stock (OTC:RECEF), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Analyst Ratings for Recce Pharmaceuticals

No data available to display

date ▲▼	ticker ▲▼	Buy Now	Company ▲▼	Current price ▲▼	Upside/Downside ▲▼	Analyst Firm ▲▼	Analyst & % Accurate ▲▼	Price Target Change ▲▼	Rating Change ▲▼	Previous / Current Rating ▲▼	Get Alert

FAQ

What is the target price for Recce Pharmaceuticals (RECEF)?

There is no price target for Recce Pharmaceuticals.

What is the most recent analyst rating for Recce Pharmaceuticals (RECEF)?

There is no analyst for Recce Pharmaceuticals.

When was the last upgrade for Recce Pharmaceuticals (RECEF)?

There is no last upgrade for Recce Pharmaceuticals.

When was the last downgrade for Recce Pharmaceuticals (RECEF)?

There is no last downgrade for Recce Pharmaceuticals.

When is the next analyst rating going to be posted or updated for Recce Pharmaceuticals (RECEF)?

There is no next analyst rating for Recce Pharmaceuticals.

Is the Analyst Rating Recce Pharmaceuticals (RECEF) correct?